Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing.
From time to time, I like to play devil's advocate as part of an exercise to identify potential wrenches and better understand the market environment we might be heading into.
In today's Flow Show, Steve Strazza and I discuss the "real" stock market and what's going on that isn't indicative of what the $QQQ or $SPY is telling us.
I'm out of town this week. So in lieu of the usual daily note, we've arranged for guest posts written by each of the members of the All Star Charts research team.
A month ago, I shared my thoughts on the early stages of Bitcoin’s next major bull run — and the opportunities beyond BTC itself. While the focus often...
